“The majority of ketamine clinics do not provide adjunct psychotherapy,” claims Natalie Ginsberg, global impact officer at the Multidisciplinary Association for Psychedelic Studies (Maps), a research and advocacy group. “A lot of these companies are forced by standard business practices to maximize profit for their shareholders, which inevitably leads to decisions that do not prioritize patient outcomes and healing.”
Originally appearing here (Archived)
